The winner will:

• Partner with King's College in their British Heart Foundation Centre of Excellence, Artificial Intelligence Centre and MedTech Hub to test, develop and validate a successful technology
• Receive access to a vast network of world leading experts in the fields of cardiovascular research (basic scientists and clinicians) to develop novel ideas
• Have an interview published in the ACC's international newsletter, distributed to over 17,000 practicing cardiologists outside the United States

• Entries that do not comply with these criteria will not be accepted. Please read carefully!
• Company must have a product or service relevant to cardiovascular health, specifically the technology is required to connect to a biosensor or be focused on functionality of a stress test
• Must be a registered company and company should have been in existence in its current form for no more than 5 years
• The innovation must be categorized as digital health/health IT or medical devices
• Each company may only enter one innovation in the challenge

More Details on Near-Patient Biosensor Technology
Wearable sensors and smartphones offer the potential to transform a clinic-based "diagnose and treat" to a community-enabled "predict and pre-empt" model of care. They can continuously measure relevant markers of CV disease such as physical activity, sleep, heart rate, blood pressure (BP), respiratory rate and single lead ECGs, and provide more objective metrics than symptoms. The clear promise of wearable sensor data needs to be transformed into clinical benefit.

Coming Soon